Compound (23) was also the focus of Xiong et al., who explored its protective action against human TNF-α-induced inflammation and cytotoxicity based on the accumulated evidence about the correlation between RA therapeutic effects and the antagonist effects against TNF-α in RA mouse models [109]. The gene discussed is TNF; the disease is rheumatoid arthritis.